In this first authoritative overview on modern cancer chemotherapy 121 international specialists have contributed their experience and recent data for what is likely to become the gold standard in the field.
Tumors/cancers are characterized by uncontrolled growths of abnormal cells that extend beyond their usual boundaries and disrupt the normal functions of affected organs and systems.
This text presents a comprehensive and state-of-the-art approach to renal mass biopsy, and reviews current techniques for obtaining samples, proper tissues processing, indications for biopsy, and treatment outcomes.
Assembling, reviewing, and synthesizing state-of-the-art information on translational research and therapies of melanoma into one convenient source, Melanoma: Translational Research and Emerging Therapies provides clinicians and researchers the necessary context and perspective to intergrate and effectively deploy cutting-edge therapies into daily
Dispelling the commonly held belief that lung cancer is always self-inflicted, this book guides patients, their loved ones, and caregivers through diagnosis, acceptance, and treatment, and provides support and hope to the tens of thousands of people coping with this illness.
Written by one of the world's leading experts in the field of nuclear medicine dosimetry, this text describes in detail the use of internal dose calculations in the practice of nuclear medicine.
This book considers how Nuclear Medicine treatments have been further developed in the past several years and are now widely applied in clinical practice, especially in oncological patients, in addition to radioiodine therapy for various thyroid diseases.
This book reflects the state of the art of our understanding of the WNT signaling system, which comprises a network of signaling pathways initiated by the secreted WNT lipoglycoproteins, which are crucial for embryonal development, stem cell regulation, tissue homeostasis and repair.
This volume evaluates the clinical patterns of resistance to sorafenib, the impact of trial design in the second-line setting and the current gold standard to define radiological resistance; describes the molecular mechanisms responsible for treatment resistance in HCC patients, including components of the immune system and tumor microenvironment; determines the role of the cancer stem cell phenotype in resistance; reviews the experimental models to study resistance; and addresses new approaches to overcome resistance to sorafenib, using successful examples from other malignancies.
In this volume, a team of internationally recognized experts provide an in-depth description of therapeutic biomarkers across a broad area of cancer research and oncology.
This book, written by global experts in the field, provides a thorough overview on fertility and pregnancy challenges and solutions in women who are being or have been treated for cancer.
Each chapter will focus on the known molecular characteristics of specific childhood cancers, focusing on how the molecular 'drivers' can be exploited from a therapeutic standpoint with currently available targeted agents.
As controlled trials have demonstrated that in many Europeancountries breast cancer mortality may be reduced bypopulation-based mammographic screening of women over theage of 50, there is mounting pressure to introduce newservice screening programmes.
This atlas is a superb guide to the use of PET-CT for the evaluation of treatment response in oncology patients based on its ability to assess tumor metabolic status.
Similar to the 1st edition, the 2nd edition of Minimally Invasive Surgical Techniques for Cancers of the Gastrointestinal Tract provides different approaches for various organs of the gastrointestinal tract.
Palliative care has become increasingly important across the spectrum of healthcare, and with it, the need for education and training of a broad range of medical practitioners not previously associated with this field of care.
Breast Cancer: A New Era in Management provides a compendium of succinct analysis of the many facets involved in the present day management of the breast cancer patient.
Angiogenesis and lymphangiogenesis have become attractive targets for drug therapy because of their key roles in a broad spectrum of pathological disease states ranging from macular degeneration to tumor growth and metastasis.
This book describes and explains how caring for adolescents and young adults with cancer (AYA) has developed into what is now a recognized and distinct field of nursing practice.
Stories in the media about the cancer-causing risks present in everyday life can cause alarm and confusion, and make it difficult to know how to alter one's lifestyle.
This book, co-authored by an internationally acclaimed team of experts in the field of pediatric oncologic imaging, provides a comprehensive update on new advances in diagnostic imaging as they relate to pediatric oncology.
Emerging Cancer Therapeutics is a trinary hard cover periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists involved in the care of patients receiving cancer treatment.
A CONCISE YET THOROUGH OVERVIEW OF THE MEDICATIONS AND APPROACHES USED IN CANCER CARE--BACKED BY THE AUTHORITY OF HARRISON'SHarrison's Manual of Oncology is a carry-anywhere guide to the care of patients with cancer.
Transforming Growth Factor-jl in Cancer Therapy, Volume I: Basicand Clinical Biology The present volume brings together a wealth of information that is fundamental to understanding the roleofTGF-~ in the pathogenesis, prevention, and treatment of cancer.
Die ständige Erweiterung der Kenntnisse über die Natur neoplastischer Erkrankungen hat eine völlige Neubearbeitung der "Histologischen Tumorklassifikation" erforderlich gemacht.
This book provides a state-of-the-art review of the biology, treatment, and other critical aspects of neuroblastoma, reflecting the dramatic advances that have been achieved in understanding and management.
This innovative book provides a unique perspective on the biomedical and societal implications of personalized medicine and how it will help mitigate the healthcare crisis and rein in ever-growing expenditure.
The development of new techniques such as immuno- phenotyping, cytogenetic investigations and, more recently, molecular studies has considerably increased our diagnostic repertoire and broadened our ideas about the biology of acute leukemias.
This book provides a comprehensive overview of the importance of molecular imaging in multiple myeloma, with detailed explanation of its clinical impact.
